南模生物: 第三届董事会第二十三次会议决议公告

Group 1 - The board of directors of Shanghai Nanfang Model Biological Technology Co., Ltd. held its 13th meeting on August 25, 2025, with all 9 directors present, including 3 independent directors [1] - The meeting discussed a request from the controlling shareholder, Tishi Consulting, to convene a temporary shareholders' meeting to review board restructuring proposals [2][3] - The proposals include adjustments to board seats, the cancellation of the supervisory board, and amendments to the company's articles of association [2][3] Group 2 - Tishi Consulting holds 35.62% of the company's shares, qualifying it to request a temporary shareholders' meeting under relevant laws and regulations [2] - The board has agreed to convene the temporary shareholders' meeting and will issue a notice within five days of the decision [6] - The voting results showed 5 votes in favor, 3 against, and 1 abstention regarding the proposals, indicating some dissent among the board members [5]